-
公开(公告)号:US20210023141A1
公开(公告)日:2021-01-28
申请号:US17042763
申请日:2019-04-03
IPC分类号: A61K35/28 , A61P15/10 , G01N33/569 , A61P35/00 , A61P1/00
摘要: The present invention relates to an isolated CD31+ cell derived from adipose-derived regenerative cells (ADRC's), for use as a medicament. The invention also relates to compositions comprising such cells. In addition, the invention relates to methods for screening for the regenerative capacity of a population of adipose-derived regenerative cells (ADRC's).